A novel selenoflavone compound as anti-obesity agent
The present invention relates to a process for producing a novel selenoflavone compound and a pharmaceutical composition for preventing or treating obesity comprising the selenoflavone compound. In the present invention, selenoflavone, especially PMSF, which has never been synthesized due to synthet...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LEE, YUN HEE JEONG, JIN HYUN YANG, WOO RAM CHOI, YONG SUNG KWON, HYUN JUNG |
| description | The present invention relates to a process for producing a novel selenoflavone compound and a pharmaceutical composition for preventing or treating obesity comprising the selenoflavone compound. In the present invention, selenoflavone, especially PMSF, which has never been synthesized due to synthetic difficulties can be synthesized through palladium-catalyzed direct C-H arylation. Since the synthesized selenoflavone has an improving effect related to activation of brown adipose tissue (BAT), the selenoflavone can be used in the composition for prevention and treatment of obesity.
본 발명은 신규한 셀레노플라본 화합물의 제조 방법 및 상기 셀레노플라본 화합물을 포함하는 비만 예방 또는 치료용 약학 조성물에 관한 것이다. 본 발명에서는 팔라듐-촉매를 사용하여 직접적 C-H 아릴화(palladium-catalyzed direct C-H arylation)를 통해 합성적인 어려움으로 인해 합성된 적이 없었던 셀레노플라본, 특히 PMSF을 합성할 수 있다. 상기 합성된 셀레노플라본은 BAT (brown adipose tissue)의 활성화와 관련된 개선 효과를 가지므로, 상기 셀레노플라본은 비만의 예방 및 치료를 위한 조성물에 사용될 수 있다. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20180106800A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20180106800A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20180106800A3</originalsourceid><addsrcrecordid>eNrjZDBxVMjLL0vNUShOzUnNy0_LSSzLz0tVSM7PLcgvzUtRSCxWSMwrydTNT0otziypVEhMT80r4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgaGFgaGBmYWBgaOxsSpAgDhuC2h</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A novel selenoflavone compound as anti-obesity agent</title><source>esp@cenet</source><creator>LEE, YUN HEE ; JEONG, JIN HYUN ; YANG, WOO RAM ; CHOI, YONG SUNG ; KWON, HYUN JUNG</creator><creatorcontrib>LEE, YUN HEE ; JEONG, JIN HYUN ; YANG, WOO RAM ; CHOI, YONG SUNG ; KWON, HYUN JUNG</creatorcontrib><description>The present invention relates to a process for producing a novel selenoflavone compound and a pharmaceutical composition for preventing or treating obesity comprising the selenoflavone compound. In the present invention, selenoflavone, especially PMSF, which has never been synthesized due to synthetic difficulties can be synthesized through palladium-catalyzed direct C-H arylation. Since the synthesized selenoflavone has an improving effect related to activation of brown adipose tissue (BAT), the selenoflavone can be used in the composition for prevention and treatment of obesity.
본 발명은 신규한 셀레노플라본 화합물의 제조 방법 및 상기 셀레노플라본 화합물을 포함하는 비만 예방 또는 치료용 약학 조성물에 관한 것이다. 본 발명에서는 팔라듐-촉매를 사용하여 직접적 C-H 아릴화(palladium-catalyzed direct C-H arylation)를 통해 합성적인 어려움으로 인해 합성된 적이 없었던 셀레노플라본, 특히 PMSF을 합성할 수 있다. 상기 합성된 셀레노플라본은 BAT (brown adipose tissue)의 활성화와 관련된 개선 효과를 가지므로, 상기 셀레노플라본은 비만의 예방 및 치료를 위한 조성물에 사용될 수 있다.</description><language>eng ; kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181001&DB=EPODOC&CC=KR&NR=20180106800A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181001&DB=EPODOC&CC=KR&NR=20180106800A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LEE, YUN HEE</creatorcontrib><creatorcontrib>JEONG, JIN HYUN</creatorcontrib><creatorcontrib>YANG, WOO RAM</creatorcontrib><creatorcontrib>CHOI, YONG SUNG</creatorcontrib><creatorcontrib>KWON, HYUN JUNG</creatorcontrib><title>A novel selenoflavone compound as anti-obesity agent</title><description>The present invention relates to a process for producing a novel selenoflavone compound and a pharmaceutical composition for preventing or treating obesity comprising the selenoflavone compound. In the present invention, selenoflavone, especially PMSF, which has never been synthesized due to synthetic difficulties can be synthesized through palladium-catalyzed direct C-H arylation. Since the synthesized selenoflavone has an improving effect related to activation of brown adipose tissue (BAT), the selenoflavone can be used in the composition for prevention and treatment of obesity.
본 발명은 신규한 셀레노플라본 화합물의 제조 방법 및 상기 셀레노플라본 화합물을 포함하는 비만 예방 또는 치료용 약학 조성물에 관한 것이다. 본 발명에서는 팔라듐-촉매를 사용하여 직접적 C-H 아릴화(palladium-catalyzed direct C-H arylation)를 통해 합성적인 어려움으로 인해 합성된 적이 없었던 셀레노플라본, 특히 PMSF을 합성할 수 있다. 상기 합성된 셀레노플라본은 BAT (brown adipose tissue)의 활성화와 관련된 개선 효과를 가지므로, 상기 셀레노플라본은 비만의 예방 및 치료를 위한 조성물에 사용될 수 있다.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBxVMjLL0vNUShOzUnNy0_LSSzLz0tVSM7PLcgvzUtRSCxWSMwrydTNT0otziypVEhMT80r4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgaGFgaGBmYWBgaOxsSpAgDhuC2h</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>LEE, YUN HEE</creator><creator>JEONG, JIN HYUN</creator><creator>YANG, WOO RAM</creator><creator>CHOI, YONG SUNG</creator><creator>KWON, HYUN JUNG</creator><scope>EVB</scope></search><sort><creationdate>20181001</creationdate><title>A novel selenoflavone compound as anti-obesity agent</title><author>LEE, YUN HEE ; JEONG, JIN HYUN ; YANG, WOO RAM ; CHOI, YONG SUNG ; KWON, HYUN JUNG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20180106800A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>LEE, YUN HEE</creatorcontrib><creatorcontrib>JEONG, JIN HYUN</creatorcontrib><creatorcontrib>YANG, WOO RAM</creatorcontrib><creatorcontrib>CHOI, YONG SUNG</creatorcontrib><creatorcontrib>KWON, HYUN JUNG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LEE, YUN HEE</au><au>JEONG, JIN HYUN</au><au>YANG, WOO RAM</au><au>CHOI, YONG SUNG</au><au>KWON, HYUN JUNG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A novel selenoflavone compound as anti-obesity agent</title><date>2018-10-01</date><risdate>2018</risdate><abstract>The present invention relates to a process for producing a novel selenoflavone compound and a pharmaceutical composition for preventing or treating obesity comprising the selenoflavone compound. In the present invention, selenoflavone, especially PMSF, which has never been synthesized due to synthetic difficulties can be synthesized through palladium-catalyzed direct C-H arylation. Since the synthesized selenoflavone has an improving effect related to activation of brown adipose tissue (BAT), the selenoflavone can be used in the composition for prevention and treatment of obesity.
본 발명은 신규한 셀레노플라본 화합물의 제조 방법 및 상기 셀레노플라본 화합물을 포함하는 비만 예방 또는 치료용 약학 조성물에 관한 것이다. 본 발명에서는 팔라듐-촉매를 사용하여 직접적 C-H 아릴화(palladium-catalyzed direct C-H arylation)를 통해 합성적인 어려움으로 인해 합성된 적이 없었던 셀레노플라본, 특히 PMSF을 합성할 수 있다. 상기 합성된 셀레노플라본은 BAT (brown adipose tissue)의 활성화와 관련된 개선 효과를 가지므로, 상기 셀레노플라본은 비만의 예방 및 치료를 위한 조성물에 사용될 수 있다.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR20180106800A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | A novel selenoflavone compound as anti-obesity agent |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T06%3A15%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LEE,%20YUN%20HEE&rft.date=2018-10-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20180106800A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |